Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5D2B

Crystal structure of a mutated catalytic domain of Human MMP12 in complex with an hydroxamate analogue of RXP470

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsSOLEIL BEAMLINE PROXIMA 2
Synchrotron siteSOLEIL
BeamlinePROXIMA 2
Temperature [K]100
Detector technologyCCD
Collection date2015-07-22
DetectorADSC QUANTUM 315r
Wavelength(s)0.9184
Spacegroup nameP 21 21 2
Unit cell lengths68.900, 63.100, 36.790
Unit cell angles90.00, 90.00, 90.00
Refinement procedure
Resolution32.453 - 1.200
R-factor0.1554
Rwork0.154
R-free0.17470
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)4gql
RMSD bond length0.005
RMSD bond angle1.067
Data reduction softwareXDS
Data scaling softwareXSCALE
Phasing softwareMOLREP
Refinement softwarePHENIX (1.8_1069)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]32.4531.230
High resolution limit [Å]1.2001.200
Rmerge0.1001.050
Number of reflections96542
<I/σ(I)>8.781.53
Completeness [%]99.696.9
Redundancy4.62.9
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION, SITTING DROP9.5293Protein : hMMP12 F171D at 820 micro-M + 10 milli-M AHA + 0.708 milli-M inhibitor. Precipitant : 20% PEG4000, 0.2 M TRIS pH 9.5 Cryoprotectant : 10 % diethylene glycol + 5 % glycerol + 10 % 1,2-propanediol + 5 % 1,4-dioxane + 25% PEG6000 + 0.1 M TRIS HCl pH 8.0

219869

PDB entries from 2024-05-15

PDB statisticsPDBj update infoContact PDBjnumon